Table 4.
Treatment preference (PQ-C and PQ-P) at week 13
| Lonapegsomatropin* | Prior daily somatropin | No preference | |||
|---|---|---|---|---|---|
| Child (n = 99), n (%) | 83 (83.8) | 9 (9.1) | 7 (7.1) | ||
|
| |||||
| Child's reason for preference, % | How often I need to get injections (number of shots a week) | (88.0) | Less injection pain | (100) | − |
| Less annoyed by the injections | (65.1) | Less bruising, redness, and/or swelling | (55.6) | ||
| Less interference with (getting in the way of) my activities | (57.8) | Less burning, stinging, and/or soreness | (55.6) | ||
|
| |||||
| Parent (n = 142),n (%) | 128 (90.1) | 7 (4.9) | 7 (4.9) | ||
|
| |||||
| Parent's reason for preference, % | How often my child needs to get injections (number of shots a week) | (95.3) | Easier to give the injection | (85.7) | − |
| Less interference with my child's activities | (68.0) | Easier to prepare the injection | (85.7) | ||
| Less interference with my activities | (53.9) | My child seems less afraid about getting injection | (71.4) | ||
The top 3 most cited reasons (check as many answers as you like) for preference are shown. PQ–C, preference questionnaire − child; PQ–P, preference questionnaire − parent.
*
Lonapegsomatropin was administered via vial/syringe.